Addressing cost-related nonadherence to oral anticancer medications through health policy reform: Challenges and opportunities

摘要

This editorial discusses several of Dean et al's proposed interventions aimed at payers and the pharmaceutical supply chain and highlights the challenges and opportunities for improving patient access to oral anticancer medications through system reform. This editorial focuses on payers and the pharmaceutical supply chain because these systems set prices and reimbursement in the United States and are directly responsible for cost-related barriers that influence the accessibility and affordability of prescription medications.